Emerge Ventures is a venture capital firm based in Singapore, founded in 2013. The firm is led by experienced entrepreneurs and focuses on supporting other entrepreneurs in achieving significant value. Emerge Ventures primarily invests in the life sciences, genomics, and software enterprise technology sectors, aiming to foster innovation and growth within these fields.
The company’s key focus is to generate and disseminate high quality content on latest and emerging developments in the field of medical science and healthcare technologies as well as industry trends for the clinicians, medical researchers, students and key decision makers in healthcare management.
MedGenome Labs Private Ltd. specializes in molecular genetic diagnostic testing, utilizing advanced technologies such as Sanger sequencing and next-generation sequencing to support personalized healthcare. The company offers a comprehensive range of genetic tests, including exome, whole genome, and mitochondrial genome sequencing, alongside various disease panels. These panels focus on hereditary cancers, somatic mutations in tumors, and genetic conditions affecting cardiac, eye, and neuromuscular health. Additionally, MedGenome provides targeted tests for genetic mutations linked to non-syndromic deafness and autism spectrum disorders. The company also maintains OncoMD, a database of cancer-related mutations sourced from peer-reviewed research. MedGenome's services are designed to guide clinicians in identifying appropriate treatment options based on genetic variations and assessing disease risk. Established in 2013 and headquartered in Chennai, India, MedGenome operates as a subsidiary of SciGenom Labs Pvt Ltd and collaborates strategically with Denali Therapeutics to enhance its research capabilities.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.